Filing Statement Ahead of MediPharm Labs Listing
Perth, Sep 25, 2018 AEST (ABN Newswire) - MMJ PhytoTech Limited (
ASX:MMJ) (MMJJF:OTCMKTS) ("MMJ") is pleased to note the filing statement related to the imminent listing, by way of a reverse takeover ("RTO"), of MediPharm Labs, Inc. ("MediPharm Labs") on the TSX Venture Exchange. The filing statement (dated 24 September 2018) can be viewed by entering "POCML 4 Inc" in the Company Name box at:
http://www.abnnewswire.net/lnk/4D85Z4M1
MMJ notes that on pages 33 and 34 of the filing statement there is a detailed description of the expected sources and uses of the CAD$20.9 million of available funds to MediPharm Labs on completion of the RTO.
MMJ has invested CAD$5 million of equity for an approximate shareholding of 6.9% in MediPharm Labs.
About MMJ Group Holdings Ltd
MMJ Group Holdings Ltd (ASX:MMJ) is a global cannabis investment company. MMJ owns a portfolio of minority investments and aims to invest across the full range of emerging cannabis-related sectors including healthcare, technology, infrastructure, logistics, processing, cultivation, equipment and retail. For MMJ's latest investor presentation and news, please visit: https://www.mmjphytotech.com.au/investors/
| ||
|
